1.
Bioorg Med Chem Lett
; 15(23): 5340-3, 2005 Dec 01.
Artículo
en Inglés
| MEDLINE
| ID: mdl-16185865
RESUMEN
The synthesis and biological activities of rapamycin (I) analogs modified at the C-40 position are reported. Emphasis placed on compounds that potentially have an improved safety profile on account of their shorter in vivo half-life when compared with rapamycin.